Business
Visionary Holdings Announces Continued Progress of Approximately US$9 Million Sales Contract
Expects Significant Milestone Advancement by the End of March 2026HONG KONG, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), continued execution progress under its previously signed commercial sales agreement with a total contract value of approximately US$9 million. The agreement, signed in September 2
About this update from Visionary Holdings Inc.
[{"type":"text","content":"Expects Significant Milestone Advancement by the End of March 2026","length":66,"tagName":"p"},{"type":"text","content":"HONG KONG, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), continued execution progress under its previously signed commercial sales agreement with a total contract value of approximately US$9 million.","length":397,"tagName":"p"},{"type":"text","content":"The agreement, signed in September 2025, is currently in the implementation stage, with service activities underway. GV Hong Kong is working closely with its business partner to advance phased implementation efforts under the terms of the agreement.","length":249,"tagName":"p"},{"type":"text","content":"Execution UpdateSince the signing of the agreement, both parties have continued to advance contractual milestones. Early-stage service activities remain in progress. Based on the current delivery schedule and client coordination progress, the Company expects the agreement to achieve further substantive execution milestones by the end of the first quarter of 2026.","length":366,"tagName":"p"},{"type":"text","content":"Any related revenue recognition and cash collection will be recorded in accordance with the terms of the agreement and applicable accounting standards.","length":151,"tagName":"p"},{"type":"text","content":"Product and Service OverviewThe commercial scope of the agreement includes:","length":76,"tagName":"p"},{"type":"text","content":"The Premier Regenerative Complex product series, positioned within high-end health management solutions; Customized VIP health services centered on individualized medical evaluations and physician-guided programs. These services are delivered within a structured medical oversight framework and are tailored based on individual health assessments.","length":347,"tagName":"p"},{"type":"text","content":"Management CommentaryMr. Hou Xiyong, Chief Executive Officer of Visionary Holdings, commented:","length":95,"tagName":"p"},{"type":"text","content":"“The continued execution of this agreement reflects our ability to effectively convert strategic partnerships into operational results. We remain committed to disciplined delivery, ...